Analyst firms · H.C. Wainwright · RARE
H.C. Wainwright RARE price target and rating history
Ultragenyx Pharmaceutical Inc. (RARE) · Health Care
H.C. Wainwright rates Ultragenyx Pharmaceutical Inc. (RARE) Buy with a $80 price target, as of its latest action on Jul 28, 2025. It has published 3 rating actions on RARE since September 2021, including 0 upgrades and 0 downgrades. Across 5 firms with a RARE price target in the last 12 months, the median target is $16.
- Current rating
- Buy
- Price target
- $80
- Median target, all firms
- $16
- Actions on RARE
- 3
H.C. Wainwright price target on RARE
Every H.C. Wainwright rating on RARE
- Jul 28, 2025
- Dec 30, 2022
- Sep 30, 2021
How other firms rate RARE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | $16 | Oct 15, 2026 |
| BofA Securities | Neutral | Sep 3, 2026 | |
| William Blair | Mkt Perform | Sep 3, 2026 | |
| Evercore ISI | In-line | $16 | Sep 3, 2026 |
| Robert W. Baird | Neutral | $16 | Sep 3, 2026 |
| Wells Fargo | Equal Weight | $18 | Sep 3, 2026 |
| Goldman Sachs | Neutral | $25 | Mar 24, 2026 |
Questions about H.C. Wainwright and RARE
- What is H.C. Wainwright's price target for RARE?
- H.C. Wainwright's latest stated price target for Ultragenyx Pharmaceutical Inc. (RARE) is $80, from its action on Jul 28, 2025.
- What is H.C. Wainwright's rating on RARE?
- H.C. Wainwright rates RARE Buy, a bullish rating, as of Jul 28, 2025.
- When did H.C. Wainwright last change its view on RARE?
- On Jul 28, 2025, H.C. Wainwright resumes coverage at Buy, price target $80.
- How does H.C. Wainwright's RARE target compare with other analysts?
- Across 5 firms with a RARE price target in the last 12 months, the median target is $16.
More RARE rating histories
All H.C. Wainwright ratingsRARE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.